Alivus Life Sciences Limited · ALIVUS
Next result 26 Oct 2026 · Q2FY27 (projected)
₹1,384.00
+0.75% on the day
Close 6 Oct 2026 · 52w ₹860 – ₹1,443
—scoreno read yet
±3.9%
typical move
on its results, either way
The daily read · from the close of 6 Oct
That day's whole field78.1
score /100rank 71 of 856
chance it beats
Nifty in 10 sessions
Nifty in 10 sessions
In the top tenth of the field
Entry reference₹1,384.00close 6 Oct
Upside reference₹1,432.94+3.5% · typical 10-session rise
Downside reference₹1,353.55-2.2% · typical 10-session fall
+2.5% over 30 sessions · +34.0% vs Nifty over 90 · 84% of its 52-week range. Layer percentiles across the field: L2 momentum 84.9, L3 vs market 75.9, L5 own record 83.2. The references are its own median ten-session rise and fall over the past year — arithmetic on its own history, not a price goal.
Its daily score over the last 60 sessions, oldest to newest; green when it sat in the top fifth, red in the bottom fifth. Of the 49 judged, 37 went the way its half of the field leaned.
How it has moved
All performers| Window | Move | vs Nifty | vs sector | vs itself | How it moved | Rank | |
|---|---|---|---|---|---|---|---|
| Week28 Sep on · 6 sessions | +1.3% | +2.9% | — | 65th pct | 3 of 6 up | 157 of 856 | |
| Month1 Sep on · 24 sessions | -1.5% | +3.9% | — | 24th pct | 11 of 24 up | 288 of 856 | |
| Quarter7 Jul on · 64 sessions | +20.3% | +27.1% | — | 81th pct | 32 of 64 up | 122 of 856 | |
| Half year7 Apr on · 125 sessions | +37.6% | +38.5% | — | 83th pct | 60 of 125 up | 222 of 855 | |
| Year7 Oct on · 246 sessions | +48.3% | +57.5% | — | 95th pct | 119 of 246 up | 123 of 855 | Stretched |
vs itself: where the move sits among this share's own moves of the same length over the past year. Our calculation, not advice.
The read
no read yet
This screen reads a company each morning in the week before its result. Its next result is 26 Oct 2026 (Q2FY27, projected); the read begins about seven days before.
Until then, what its own record says is below: it moves ±3.9% on results on average and was up after ten sessions in 4 of 7.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
What its results record says
7 results · ten sessions after each · from the close before the result
Up after ten sessions
4 of 7
mean +3.3% · median +1.5%
Best point reached
+6.0%
median · as high as +27.2%
Worst point reached
-1.5%
median · as low as -13.7%
Traded 5% above
4 of 7
closed at least that far up at some point
worst point to best point
where it ended after ten sessions
This is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market
same 90 sessions · every line starts at 0%Alivus Life Sciences LimitedNIFTY 50 (market)
No sector index is mapped for this company, so only the market is shown.
Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
After 10 sessions
+26.6%
₹1,095.70 on 30 Jul → ₹1,386.70 on 14 Aug
On the result day
+5.9%
close on 31 Jul against the close before
Highest it traded
+29.4%
₹1,418.00 on 11 Aug · best close +27.2%
Lowest it traded
+1.1%
₹1,108.00 on 31 Jul · worst close +5.9%
Q4FY26 15 May 2026
-1.5% after 10 · high +5.7% · low -3.9%
Q3FY26 23 Jan 2026
+8.9% after 10 · high +13.8% · low +0.0%
Q2FY26 7 Nov 2025
+1.5% after 10 · high +6.7% · low +1.3%
Ten sessions after each result
share vs market · move from the close before the resultShareNIFTY 50
Results record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 31 Jul 2026 | +3.6% | +10.8% | +26.6% | +0.2% | +26.4% | — | 2.8 | Rev 6% · PAT 32% YoY |
| Q4FY26 | 15 May 2026 | -0.4% | -0.8% | -0.8% | -0.6% | -0.2% | — | 1.8 | Rev 6% · PAT 15% YoY |
| Q3FY26 | 23 Jan 2026 | +3.0% | +3.1% | +8.9% | +2.3% | +6.6% | — | 3.2 | Rev 5% · PAT 10% YoY |
| Q2FY26 | 7 Nov 2025 | +3.9% | +3.4% | +1.5% | +2.2% | -0.7% | — | 1.6 | Rev 16% · PAT 36% YoY |
| Q1FY26 | 4 Aug 2025 | -1.3% | -1.4% | -3.3% | +1.7% | -5.0% | — | 1.6 | Rev 2% · PAT 9% YoY |
| Q4FY25 | 16 May 2025 | -0.9% | -5.1% | -13.7% | -1.2% | -12.4% | — | 2.1 | Rev 21% · PAT 45% YoY |
| Q3FY25 | 24 Jan 2025 | +2.8% | +2.6% | +4.9% | +1.5% | +3.4% | — | 0.8 | — |
Reported figures
₹ crore; from the exchange's XBRL filingsRevenue ₹ cr
Net profit ₹ cr
| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 640 | +6.4% | 160 | +31.7% | 33.1% | 13.04 |
| Q4FY26 | 31 Mar 2026 | 689 | +6.1% | 162 | +14.7% | 31.1% | 13.23 |
| Q3FY26 | 31 Dec 2025 | 672 | +4.8% | 150 | +9.7% | 30.6% | 12.25 |
| Q2FY26 | 30 Sep 2025 | 587 | +16.0% | 130 | +36.4% | 30.5% | 10.60 |
| Q1FY26 | 30 Jun 2025 | 601 | +2.2% | 121 | +9.0% | 28.6% | 9.91 |
| Q4FY25 | 31 Mar 2025 | 649 | +21.0% | 141 | +44.9% | 30.5% | 11.57 |
| Q3FY25 | 31 Dec 2024 | 641 | — | 136 | — | 29.7% | 11.18 |
| Q2FY25 | 30 Sep 2024 | 506 | — | 95 | — | 26.5% | 7.78 |
| Q1FY25 | 30 Jun 2024 | 588 | — | 111 | — | 27.1% | 9.10 |
| Q4FY24 | 31 Mar 2024 | 536 | — | 97 | — | 26.4% | 7.99 |
| Q3FY24 | 31 Dec 2023 | 572 | +5.9% | 118 | +13.1% | 30.1% | 9.69 |
| Q2FY24 | 30 Sep 2023 | 595 | +16.9% | 118 | +11.1% | 28.1% | 9.69 |
Post-mortems
Every result in full →- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- Delivery share rose 15 points in the fortnight before — someone was taking stock home.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.